Resource Type

Journal Article 140

Year

2024 4

2023 24

2022 26

2021 30

2020 46

2019 3

2015 1

2010 1

2008 1

open ︾

Keywords

COVID-19 71

SARS-CoV-2 26

Coronavirus disease 2019 8

coronavirus disease 2019 (COVID-19) 5

traditional Chinese medicine 4

Coronavirus disease 3

Pneumonia 3

2019-nCoV 2

Airborne transmission 2

COVID-19 pandemic 2

COVID-19 vaccine 2

China 2

Clinical characteristics 2

Comorbidities 2

Efficacy 2

Influenza 2

Reusable 2

SEIR model 2

Safety 2

open ︾

Search scope:

排序： Display mode:

Passive antibody therapy in emerging infectious diseases

Frontiers of Medicine 2023, Volume 17, Issue 6,   Pages 1117-1134 doi: 10.1007/s11684-023-1021-y

Abstract: The epidemic of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirusapplied in passive immunotherapy have yielded positive outcomes and played a crucial role in the early COVID-19-19 treatment.action mechanism, clinical research results, challenges, and safety profile associated with the use of COVID-19-19 convalescent plasma, hyperimmunoglobulin, and mAbs were summarized.

Keywords： SARS-CoV-2     COVID-19     convalescent plasma     hyperimmunoglobulin     neutralizing monoclonal antibodies    

HTML PDF Collect

Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19-19 convalescents

Frontiers of Medicine 2023, Volume 17, Issue 4,   Pages 747-757 doi: 10.1007/s11684-022-0954-x

Abstract: Emerging SARS-CoV-2 variants have made COVID-19 convalescents susceptible to re-infection and have raisedTo this end, a study on a long-term cohort of 208 participants who have recovered from COVID-19 was conductedTwo doses of inactivated vaccine among COVID-19 convalescents are therefore recommended for the preventionof the COVID-19 pandemic, and vaccination guidelines and policies need to be updated.

Keywords： COVID-19 convalescent     SARS-CoV-2     inactivated vaccination     neutralizing antibody     B cell response    

HTML PDF Collect

Innovation-driven trend shaping COVID-19 vaccine development in China

Frontiers of Medicine 2023, Volume 17, Issue 6,   Pages 1096-1116 doi: 10.1007/s11684-023-1034-6

Abstract: Confronted with the coronavirus disease 2019 (COVID-19) pandemic, China has become an asset in tacklingprotein of SARS-CoV-2 or inactivated whole virus are a cornerstone of the public health response to COVID-19.

Keywords： SARS-CoV-2     COVID-19 vaccine     vaccine development    

HTML PDF Collect

The role played by traditional Chinese medicine in preventing and treating COVID-19 in China

Qingwei Li, Han Wang, Xiuyang Li, Yujiao Zheng, Yu Wei, Pei Zhang, Qiyou Ding, Jiaran Lin, Shuang Tang, Yikun Zhao, Linhua Zhao, Xiaolin Tong

Frontiers of Medicine 2020, Volume 14, Issue 5,   Pages 681-688 doi: 10.1007/s11684-020-0801-x

Abstract: , an ancient system of alternative medicine, played an active role in the prevention and control of COVID-19-19 in China.of the current global pandemic, TCM-related measures might open up a new channel in the control of COVID-19-19 in other countries and regions.patients, and describe how TCM effectively treated patients afflicted with the COVID-19.

Keywords： traditional Chinese medicine     COVID-19     Wuchang pattern     mobile cabin hospital     convalescent patients     three    

HTML PDF Collect

A review of the safety and efficacy of current COVID-19 vaccines

Frontiers of Medicine 2022, Volume 16, Issue 1,   Pages 39-55 doi: 10.1007/s11684-021-0893-y

Abstract: Vaccination is the most effective and feasible way to contain the coronavirus disease 2019 (COVID-19)The rapid development of effective COVID-19 vaccines is an extraordinary achievement.study reviewed the efficacy/effectiveness, immunogenicity, and safety profile of the 12 most progressed COVID-19-19 vaccines and discussed the challenges and prospects of the vaccine-based approaches in a global crisis

Keywords： COVID-19     SARS-CoV-2     vaccine     safety     efficacy     effectiveness     immunogenicity    

HTML PDF Collect

SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 185-195 doi: 10.1007/s11684-021-0913-y

Abstract: its genomic sequence with the world, has greatly facilitated the development of coronavirus disease (COVID-19-19) diagnostics, drugs, and vaccines.combinations and immunization strategies to provide sufficient and sustainable immune protection against COVID-19.

Keywords： COVID-19     pandemics     SARS-CoV-2     vaccination    

HTML PDF Collect

COVID-19: why not learn from the past?

Frontiers of Medicine 2021, Volume 15, Issue 5,   Pages 776-781 doi: 10.1007/s11684-021-0883-0

HTML PDF Collect

Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy

Frontiers of Medicine 2024, Volume 18, Issue 1,   Pages 19-30 doi: 10.1007/s11684-024-1074-6

Abstract: coronavirus SARS-CoV-2 infection in early December 2019, which was later named coronavirus disease 2019 (COVID-19-19) by the World Health Organization (WHO), rapidly spread across the world.After more than three years’ fighting against this disease, China downgraded the management of COVID-19Experiences against COVID-19 from China and the whole world should be learned to prepare well for theThis article gives a systematic review of the trajectory of COVID-19 development in China, summarizes

Keywords： COVID-19     public health     response and control strategy     science-based policy making    

HTML PDF Collect

Emergence of SARS and COVID-19 and preparedness for the next emerging disease X

Frontiers of Medicine 2024, Volume 18, Issue 1,   Pages 1-18 doi: 10.1007/s11684-024-1066-6

Abstract: Severe acute respiratory syndrome (SARS) and coronavirus disease 2019 (COVID-19) are two human coronavirus

Keywords： SARS     COVID-19     coronavirus    

HTML PDF Collect

Repercussions of COVID-19 pandemic on solid waste generation and management strategies

Frontiers of Environmental Science & Engineering 2021, Volume 15, Issue 6, doi: 10.1007/s11783-021-1407-5

Abstract:

• Implication of COVID-19 on medical waste and MSW generation is studied

Keywords： COVID-19     Medical waste     Personal protective equipment     Municipal solid waste     Waste management    

HTML PDF Collect

Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center

Frontiers of Medicine 2022, Volume 16, Issue 1,   Pages 111-125 doi: 10.1007/s11684-021-0854-5

Abstract: The coronavirus disease 2019 (COVID-19) has spread globally.Although mixed liver impairment has been reported in COVID-19 patients, the association of liver injurycaused by specific subtype especially chronic hepatitis B (CHB) with COVID-19 has not been elucidatedmulti-center, retrospective, and observational cohort study, 109 CHB and 327 non-CHB patients with COVID-19In conclusion, COVID-19 patients with CHB were more likely to develop into severe illness and die.

Keywords： COVID-19     chronic hepatitis B     liver injury     coagulation dysfunction    

HTML PDF Collect

Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant

Frontiers of Medicine 2023, Volume 17, Issue 3,   Pages 576-580 doi: 10.1007/s11684-023-0991-0

Abstract: Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant

Keywords： variant    

HTML PDF Collect

Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak

Frontiers of Medicine 2023, Volume 17, Issue 3,   Pages 562-575 doi: 10.1007/s11684-022-0977-3

Abstract: The Omicron family of SARS-CoV-2 variants are currently driving the COVID-19 pandemic.In particular, severe/critical cases of COVID-19 post BA.2.2 infection were associated with less pro-inflammatoryFurthermore, even though age was a critical risk factor of the severity of COVID-19 post BA.2.2 infection, vaccination-elicited protection against severe/critical COVID-19 reached 90.15% in

Keywords： SARS-CoV-2     COVID-19     host response     bronchoalveolar lavage fluid (BALF)    

HTML PDF Collect

Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine

Frontiers of Medicine doi: 10.1007/s11684-023-1054-2

Abstract: Corona virus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoVthrombocytopenic purpura (TTP) has been reported after administration of mRNA- or adenoviral vector-based COVID-19-19 vaccines, including Ad26.COV2-S, BNT162b2, mRNA-1273, and ChAdOx1 nCov-19.The number of patients with TTP was 12 in 2019, 6 in 2020, 16 in 2021, and 19 in 2022.To the authors’ knowledge, this report is the first report of TTP associated with inactivated COVID-19

Keywords： thrombotic thrombocytopenia purpura (TTP)     corona virus disease 2019 (COVID-19)     CoronaVac     acute respiratory    

HTML PDF Collect

Seroprevalence of influenza viruses in Shandong, Northern China during the COVID-19 pandemic

Frontiers of Medicine 2022, Volume 16, Issue 6,   Pages 984-990 doi: 10.1007/s11684-022-0930-5

Abstract: NPIs) have been commonly deployed to prevent and control the spread of the coronavirus disease 2019 (COVID-19meta-analyses was adopted to compare the seroprevalence of influenza antibodies before and during the COVID-19-19 pandemic.meta-analysis showed that antibodies against A/H1N1pdm09 and A/H3N2 were significantly low in adults after the COVID-19-19 pandemic ( P < 0.01).

Keywords： influenza virus     seroprevalence     antibody     COVID-19     cross-sectional study    

HTML PDF Collect

Title Author Date Type Operation

Passive antibody therapy in emerging infectious diseases

Journal Article

Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19-19 convalescents

Journal Article

Innovation-driven trend shaping COVID-19 vaccine development in China

Journal Article

The role played by traditional Chinese medicine in preventing and treating COVID-19 in China

Qingwei Li, Han Wang, Xiuyang Li, Yujiao Zheng, Yu Wei, Pei Zhang, Qiyou Ding, Jiaran Lin, Shuang Tang, Yikun Zhao, Linhua Zhao, Xiaolin Tong

Journal Article

A review of the safety and efficacy of current COVID-19 vaccines

Journal Article

SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic

Journal Article

COVID-19: why not learn from the past?

Journal Article

Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy

Journal Article

Emergence of SARS and COVID-19 and preparedness for the next emerging disease X

Journal Article

Repercussions of COVID-19 pandemic on solid waste generation and management strategies

Journal Article

Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center

Journal Article

Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant

Journal Article

Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak

Journal Article

Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine

Journal Article

Seroprevalence of influenza viruses in Shandong, Northern China during the COVID-19 pandemic

Journal Article